Affordable access RxAll operates a digital infrastructure that connects hospitals, pharmacies, and patients to high quality medicines at manufacturer and wholesale prices, presenting a revenue opportunity in expanding B2B2C distribution partnerships and wholesale pricing agreements across more markets in Africa and beyond.

Authentication edge RxScanner provides instant drug testing to authenticate medicines sold by networked sellers. This capability can be leveraged to secure growth in supplier onboarding, win more hospital and clinic customers seeking counterfeit-resistant supply chains, and offer value-added services around traceability and quality assurance.

Financing lever Embedded fintech RxPay enables invoice financing for buyers on the platform. This presents a cross-sell opportunity to lenders and financial partners, as well as potential to upsell credit facilities to larger hospital groups and pharmacy chains seeking improved cash flow and stock availability.

Expansion momentum RxAll has a track record of regional expansion and recognition (Hello Tomorrow Global Challenge, World Changing Ideas Awards) plus recent new outlets and office growth in West Africa. This signals readiness to scale partnerships, local distributors, and tech-enabled pharmacy networks in additional markets.

Tech-enabled trust A suite of products including RxPOS for in-store and online inventory management and RxDelivered marketplace positions RxAll as a one-stop platform for medicine procurement and distribution. There are opportunities to upsell to existing wholesalers and pharma companies by offering integrated inventory, digital payments, and logistics services across broader geographies.